About Impella® Heart Pumps
What are Impella Heart Pumps?
Impella, the world’s smallest heart pump, is a support system of percutaneous catheter-based technology offering hemodynamic support to the heart. Impella has been treating patients in the United States since 2008. Impella heart pumps allow the heart to rest and recover by temporarily assisting the pumping function of the heart to efficiently deliver blood and oxygen to the entire body.
Impella is the only U.S. FDA-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock.
Stories of Recovery with Impella
Following her Protected PCI procedure, Mattie felt an immediate improvement in her health.
10 days after delivering her daughter, Jara began experiencing severe weakness and difficulty breathing.
Mongin's heart recovery after the temporary support of Impella heart pump during his Protected PCI procedure.
Protected PCI with Impella
Reduces Heart Failure Symptoms
such as fatigue, shortness of breath, swelling, and coughing.1,5 In a clinical trial, 8-in-10 patients experience improved quality of life5
Fewer Days in the Hospital
after your procedure compared to traditional therapy such as the intra-aortic balloon pump2, 3, 4, 6, 7
Fewer Repeat Visits
to the hospital for heart-related issues than traditional therapy such as the intra-aortic balloon pump4
- Dangas, G.D., et al. (2014). Am J Cardiol, 113(2), 222-228.
- Maini, B., et al. (2014). Catheter Cardiovasc Interv, 83(6), E183-E192.
- Gregory, D., et al. (2013). J Manag Care Med, 16(1), 61-69.
- Gregory, D., et al. (2013). Am Health Drug Benefits, 6(2), 88-99.
- O’Neill, W.W., et al. (2012). Circulation, 126(14), 1717-1727.
- O’Neill, W.W., et al. (2014). J Interviev Cardiol, 27(1), 1-11.
- Roos, J.B., et al. (2013). J Med Econ, 16(3), 3381-390.
- PROTECT II Data on File